Previous studies indicated that inhibition of Trib1 caused atherogenic dyslipidemia [8], while overexpression [6] or rescue [7] of Trib1 remodeled lipid metabolism homeostasis. The gene discussed is TRIB1; the disease is metabolic syndrome.